close to approving another new drug for obesity

December 1996

The FDA is getting close to approving another new drug for obesity...Meridia (sibutramine) from Knoll.

Meridia is a serotonin AND norepinephrine reuptake inhibitor. It's in the same class as the antidepressant Effexor (venlafaxine).

In fact, Meridia was originally being developed as an antidepressant. The manufacturer switched gears when they noticed that it causes weight loss. The weight loss market is a lot less crowded than the antidepressant market.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote